Back
AC Immune SA Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
ACIU
AC Immune SA
Last Price:
3.29
Seasonality Move:
-0.23%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...AC Immune SA Price Quote
$3.29
+0.05 (+1.54%)
(Updated: November 21, 2024 at 5:15 PM ET)
AC Immune SA Key Stats
Buy
58
AC Immune SA (ACIU)
is a Buy
Day range:
$3.22 - $3.41
52-week range:
$2.25 - $5.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.07%
Volume:
58.6K
Avg. volume:
119K
1-year change:
1.57%
Market cap:
$320.6M
Revenue:
$16.5M
EPS:
$-0.46
How Much Does AC Immune SA Make?
Data Unavailable
Is AC Immune SA Growing As A Company?
Data Unavailable
AC Immune SA Stock Price Performance
-
Did AC Immune SA Stock Go Up Last Month?
AC Immune SA share price went up by 3.51% last month -
Did ACIU's Share Price Rise Over The Last Year?
ACIU share price rose by 1.57% over the past 1 year
What Is AC Immune SA 52-Week High & Low?
-
What Is AC Immune SA’s 52-Week High Share Price?
AC Immune SA has traded as high as $5.14 over the past 52 weeks -
What Is AC Immune SA’s 52-Week Low Share Price?
AC Immune SA has traded as low as $2.25 over the past 52 weeks
AC Immune SA Price To Free Cash Flow
-
Is AC Immune SA Stock Overvalued?
AC Immune SA is trading at a price to free cash flow ratio of 6.10 -
Is AC Immune SA Stock Undervalued?
AC Immune SA EV to Free Cash Flow ratio is 2.59 -
What Is AC Immune SA’s Price Earnings Growth Ratio?
ACIU PEG ratio is 0.00 -
Is AC Immune SA Trading At A Premium To Earnings?
AC Immune SA EV to EBIT ratio is 0.00
Is It Risky To Buy AC Immune SA?
-
How Much Debt Does AC Immune SA Have?
Total long term debt quarterly is $0 -
How Much Cash Does AC Immune SA Have?
Cash and short term investments quarterly total is $187.7M -
What Is AC Immune SA’s Book Value Per Share?
Book value per share is 1.56
Is AC Immune SA Cash Flow Positive?
-
What Is ACIU Cash Flow From Operations?
Cash flow from operations (TTM) is $52.1M -
What Is AC Immune SA’s Cash Flow From Financing?
Cash flow from financing (TTM) is $44.6M -
What Is AC Immune SA’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$92.2M
AC Immune SA Return On Invested Capital
-
Is Management Doing A Good Job?
ACIU return on invested capital is -28.55% -
What Is AC Immune SA Return On Assets?
ROA measures how assets are converting to revenues and is -20.02% -
What Is ACIU Return On Equity?
ROE is a measure of profitability and is -28.55%
AC Immune SA Earnings Date & Stock Price
-
What Is AC Immune SA's Stock Price Today?
A single share of ACIU can be purchased today for 3.24 -
What Is AC Immune SA’s Stock Symbol?
AC Immune SA trades on the nasdaq under the ticker symbol: ACIU -
When Is AC Immune SA’s Next Earnings Date?
The next quarterly earnings date for AC Immune SA is scheduled on February 6, 2025 -
When Is ACIU's next ex-dividend date?
AC Immune SA's next ex-dividend date is November 21, 2024 -
How To Buy AC Immune SA Stock?
You can buy AC Immune SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AC Immune SA Competitors
-
Who Are AC Immune SA's Competitors?
Below is a list of companies who compete with AC Immune SA or are related in some way:
AC Immune SA Dividend Yield
-
What Is ACIU Dividend Yield?
AC Immune SA’s dividend yield currently is 0% -
What Is AC Immune SA’s Payout Ratio?
AC Immune SA’s payout ratio is 0% -
When Did AC Immune SA Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is AC Immune SA’s Dividend Per Share?
AC Immune SA pays a dividend of $0.00 per share
AC Immune SA Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 125.81% |
| Revenue: | 0% | 250.11% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 10.15 |
| Upside from Last Price: | 213.31% |